BioVaxys Technology Corp.
BVAXF
$0.0389
$0.00010.26%
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 355.30K | 116.20K | 721.40K | 700.00 | 300.00 |
| Total Receivables | 272.60K | 101.40K | 222.00K | 63.00K | 197.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 113.40K | 60.80K | 159.90K | 18.00K | 516.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 741.30K | 278.40K | 1.10M | 81.70K | 714.90K |
|
|
|||||
| Total Current Assets | 741.30K | 278.40K | 1.10M | 81.70K | 714.90K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.00M | 1.01M | -- | -- | 232.10K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 126.90K |
| Total Assets | 1.74M | 1.29M | 1.10M | 81.70K | 1.07M |
|
|
|||||
| Total Accounts Payable | 1.09M | 1.12M | 1.28M | 1.91M | 1.13M |
| Total Accrued Expenses | 771.00K | 861.50K | 793.10K | 597.40K | 420.50K |
| Short-term Debt | 58.80K | 47.30K | 73.30K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.92M | 2.03M | 2.15M | 2.51M | 1.55M |
|
|
|||||
| Total Current Liabilities | 1.92M | 2.03M | 2.15M | 2.51M | 1.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 58.80K | 47.30K | 73.30K | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.92M | 2.03M | 2.15M | 2.51M | 1.55M |
|
|
|||||
| Common Stock & APIC | 18.91M | 17.57M | 17.45M | 15.83M | 15.86M |
| Retained Earnings | -20.64M | -19.88M | -20.01M | -19.65M | -17.96M |
| Treasury Stock & Other | 1.55M | 1.56M | 1.52M | 1.39M | 1.62M |
| Total Common Equity | -180.40K | -745.90K | -1.05M | -2.43M | -474.50K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -180.40K | -745.90K | -1.05M | -2.43M | -474.50K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -180.40K | -745.90K | -1.05M | -2.43M | -474.50K |
|
|
|||||
